2652 — CF PharmTech Cashflow Statement
0.000.00%
Last trade - 00:00- HK$15.56bn
- HK$15.31bn
- CNY607.75m
Annual cashflow statement for CF PharmTech, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS |
| Standards: | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final |
| Net Income/Starting Line | -70.6 | 22.4 | 19.2 |
| Depreciation | |||
| Amortisation | |||
| Non-Cash Items | 2.54 | 9.55 | 5.19 |
| Unusual Items | |||
| Equity in Net Earnings/Losses | |||
| Other Non-Cash Items | |||
| Changes in Working Capital | 74.6 | 30.1 | 11.9 |
| Change in Accounts Receivable | |||
| Change in Inventories | |||
| Change in Prepaid Expenses | |||
| Change in Other Assets | |||
| Change in Accounts Payable | |||
| Change in Other Liabilities | |||
| Cash from Operating Activities | 45.5 | 116 | 96.5 |
| Capital Expenditures | -121 | -138 | -201 |
| Purchase of Fixed Assets | |||
| Purchase / Acquisition of Intangibles | |||
| Other Investing Cash Flow Items | -30.8 | 10.7 | 87.2 |
| Sale/Maturity of Investment | |||
| Purchase of Investments | |||
| Other Investing Cash Flow | |||
| Cash from Investing Activities | -151 | -128 | -113 |
| Financing Cash Flow Items | -1.4 | -8.58 | -20.3 |
| Other Financing Cash Flow | |||
| Net Issuance / Retirement of Debt | |||
| Cash from Financing Activities | -5.41 | 7.88 | 28.7 |
| Foreign Exchange Effects | |||
| Beginning Cash Balance | |||
| Ending Cash Balance | |||
| Net Change in Cash | -108 | -4.23 | 11.3 |